Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Poin
Go back to Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Poin| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 15.91 -0.44 (2.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.35 | 52 Week High | $3.65 | |||
| Open | $16.30 | 52 Week Low | $1.24 | |||
| Day High | $16.41 | P/E | N/A | |||
| Day Low | $15.87 | EPS | $0.00 | |||
| Volume | 75,133 | |||||
